Femtosecond lasers for laser in situ keratomileusis: a systematic review and meta-analysis by Huhtala, Anne et al.
Clinical Ophthalmology
© 2016 Huhtala et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php 
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you 
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission 
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Clinical Ophthalmology 2016:10 393–404submit your manuscript | www.dovepress.com
Dovepress 
393
http://dx.doi.org/10.2147/OPTH.S99394
Dovepress
O R I G I N A L  R E S E A R C H
open access to scientific and medical research
Open Access Full Text Article
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Purpose: The aim of this study was to review and meta-analyze whether there are differences 
between reported femtosecond (FS) lasers for laser-assisted in situ keratomileusis (LASIK) 
in terms of efficacy, predictability, and safety as primary outcomes and corneal flap thickness 
measurements and pre- and postoperative complications as secondary outcomes.
Methods: A comprehensive literature search of PubMed, Science Direct, Scopus, and Cochrane 
CENTRAL Trials Library databases was conducted to identify the relevant prospective random-
ized controlled trials of FS lasers for LASIK. Thirty-one articles describing a total of 5,404 eyes 
were included.
Results: Based on efficacy, IntraLase FS 10 and 30 kHz gave the best results. Based on pre-
dictability and safety, there were no differences between various FS lasers. FEMTO LDV and 
IntraLase FS 60 kHz produced the most accurate flap thicknesses. IntraLase and Wavelight 
SF200 had the fewest intraoperative complications. IntraLase, Visumax, and Wavelight FS200 
had the most seldom postoperative complications.
Conclusion: There were dissimilarities between different FS lasers based on efficacy and 
intraoperative and postoperative complications. All FS lasers were predictable and safe for 
making corneal flaps in LASIK.
Keywords: femtosecond laser, laser in situ keratomileusis, LASIK, meta-analysis
Introduction
Laser-assisted in situ keratomileusis (LASIK) is the most commonly used refractive 
surgery technique for the correction of myopia, hyperopia, and astigmatism.1,2 The 
first phase of LASIK, the creation of a corneal flap, is the most critical step of LASIK, 
and it affects the visual outcome of the whole procedure. The flap creation is followed 
by excimer laser ablation of the exposed stroma after which the flap is repositioned. 
The technological evolution of flap creation has emerged from mechanical manually 
guided microkeratomes to automated microkeratomes and single-use microkeratomes, 
and most recently to femtosecond (FS) laser technology.3,4 In the FS laser technology, 
FS laser photodisrupts tissue at a preset depth and produces microcavitation bubbles 
consisting of water and carbon dioxide.5 The expansion of these bubbles separates the 
corneal lamellae and forms a resection plane.5
There are several FS lasers on the market. IntraLase, now produced by Abbott Medical 
Optics Inc. (Santa Ana, CA, USA), was the first FS laser keratome introduced in the USA 
in 2001.6 Technolas Femtosecond Workstation, formerly known as Femtec, by Technolas 
Perfect Vision (Munich, Germany), was introduced immediately after the market launch 
of IntraLase.7 FEMTO LDV by Ziemer Ophthalmic Systems (Port, Switzerland) was 
introduced in the late 2005, and Visumax by Carl Zeiss Meditec AG (Jena, Germany) 
in the fall 2006.7 Wavelight FS200 by Alcon Laboratories, Inc. (Fort Worth, TX, USA) 
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received the US Food and Drug Administration clearance for 
marketing in the USA in the late 2010.8
FS laser technology has been increasingly used in 
LASIK. According to a poll conducted in 2006, .30% of the 
LASIK flaps were created by FS laser,9 while according to a 
MarketScope’s second-quarter survey for the year 2010, ∼70% 
of the LASIK flaps were created using an FS laser.10 As the 
published meta-analysis studies for FS lasers for LASIK have 
been concentrated only on IntraLase,10,11 the current study 
was undertaken to review and meta-analyze whether there are 
differences between reported FS lasers for LASIK in terms of 
efficacy, predictability, and safety as primary outcomes and 
corneal flap thickness measurements (difference from the 
target flap thickness and combined standard deviation [SD]) 
and complications as secondary outcomes.
Materials and methods
Literature search strategy
Comprehensive literature searches of PubMed and Science 
Direct databases were first conducted on December 2, 2013. 
The literature search of Scopus database was conducted 
on March 10, 2014, and another literature search of the 
Cochrane CENTRAL Trials database on October 4, 2014. 
After the review process, all the databases were rechecked 
on December 28, 2015, for newer publications. The litera-
ture searches were conducted by using the following terms: 
“femtosecond laser lasik clinical controlled randomized” 
and “femtosecond laser lasik flap thickness controlled ran-
domized” without date limitations. Language was restricted 
to English. Citations initially selected were first retrieved 
as titles by one reviewer (AH). After the initial screening, 
potentially relevant articles were retrieved as abstracts and 
screened by all authors. After this step, relevant articles were 
retrieved as complete papers and assessed for compliance.
Quality scoring
The quality of each study was assessed using the Jadad 
et al12 score with a scale of 0–5. Each study was assessed by 
three main aspects of study design: randomizing, masking, 
and participant withdrawals/dropouts. One point was given 
for the presence of randomizing, masking, and participant 
withdrawals/dropouts. If randomizing and blinding were 
appropriate, one additional point was added to each. Studies 
scoring ,3 points were considered to be of low quality.
Outcome measures
The primary outcome measures were efficacy, predictability, 
and safety. The efficacy measure was the proportion of eyes 
achieving an uncorrected distance visual acuity (UDVA), an 
UDVA of 20/20 or better. The predictability measure was 
refraction within ±0.5 diopters (D) of mean target spherical 
equivalent refraction. The safety measure was a loss of $2 
Snellen lines of CDVA, a corrected distance visual acuity. 
Secondary outcome measures were flap thickness measure-
ments (mean flap thickness and flap predictability as SD), 
and intraoperative and postoperative complication rates. For 
primary outcome measures, hyperopic eyes were excluded 
from the analysis.
Statistical methods
The data were pooled together for different FS lasers. Percent-
age values were calculated back to basic count values in order to 
make nonparametric analysis possible. Statistical significance 
for efficacy, predictability, safety, and intra- and postoperative 
complications was evaluated with the chi-square test. Corneal 
flap thickness measurements were also pooled together and 
analyzed with the one-way analysis of variance (ANOVA) 
(SigmaPlot; Systat Software Inc., San Jose, CA, USA). In this 
meta-analysis, which included several previously published 
studies, P-value ,0.001 was considered significant.
Results
Results of the literature search
Figure 1 shows the flowchart of the studies from the initial 
literature search to the final inclusion. Based on the full paper 
review, 21 controlled randomized trials and ten prospective 
or retrospective nonrandomized studies were included in 
the meta-analysis.
Primary outcome measures
Table 1 shows the main preoperative characteristics of the 
31 studies describing a total of 5,404 eyes included in the 
meta-analysis. Studies written in bold (nine studies) have 
been included in the previously published meta-analysis 
studies10,11 concerning FS laser for LASIK. Postoperative 
characteristics for primary and secondary outcomes are 
presented in Table 2.
Efficacy
Among the different IntraLase types, the efficacy 
ranged from 85.1% (IntraLase FS 60 kHz, seven studies 
included13–19) to 100% (IntraLase FS 1020 and 30 kHz,21 
Figure 2). For the most commonly reported IntraLase FS 
60 kHz, the average efficacy was 85.1%. In one study, 
IntraLase FS 60 or 150 kHz22 was used and its efficacy 
was 98.3%. For IntraLase 150 kHz,19,23–25 the average 
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Figure 1 Flowchart of study selection.
efficacy was 93.7%. For FEMTO LDV,26,27 the average 
efficacy was 91.3%. For Visumax18,24,28 and Wavelight 
FS200,29,30 the average efficacy rates were 79.1% and 
83.6%, respectively.
Predictability
The average predictability for the different IntraLase types 
ranged from 91.0% (IntraLase FS 60 kHz14–19) to 95.9% 
(IntraLase FS 30 kHz;21,31 Figure 3). FEMTO LDV26,27 had 
the average predictability of 89.4%. For Visumax18,24 and 
Wavelight FS200,29,30 the average predictabilities were 87.1% 
and 90.5%, respectively.
Safety
The average safety percentage was zero or very close 
to zero for all the studied FS laser types (Figure 4). For 
IntraLase FS 1532–36 and 30 kHz,21,31,37 the average safety was 
0.4% and 0.7%, respectively. For IntraLase FS 60 kHz,13–18 it 
was 0.2%. For Wavelight FS 200,29,30 it was 0.5%.
Secondary outcome measures
Flap thickness measurements
The average difference from the target flap thickness 
for IntraLase FS 3031,37 and 60 kHz13,14,16,38–40 was +0.8 
and +0.6 µm, respectively (Figure 5). For IntraLase FS 
15 kHz,33,34,41 the average difference from the target flap 
thickness was much bigger, +6.7 µm. For FEMTO LDV,26,40,42 
the average difference from the target flap thickness was 
5.3 µm less than intended. For Visumax,28,40 the difference 
from the target was 10.6 µm more than intended. Wavelight 
FS20029,30 produced corneal flaps that were close to the 
intended value (difference from the target flap thickness 
was +0.03 µm). The average SD for IntraLase FS 15 and 
30 kHz was 15.5 and 13.8 µm, respectively. For the most 
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Figure 3 Predictability, the proportion of eyes within ±0.5 D of target refraction after FS laser for LASIK.
Abbreviations: χ2, chi-square statistic; CI, confidence interval; D, diopters; df, degrees of freedom; FS, femtosecond; LASIK, laser-assisted in situ keratomileusis; 
ns, nonsignificant.
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Figure 2 Efficacy, the proportion of eyes within UDVA $20/20 after FS laser for LASIK.
Abbreviations: χ2, chi-square statistic; CI, confidence interval; df, degrees of freedom; FS, femtosecond; LASIK, laser-assisted in situ keratomileusis; UDVA, uncorrected 
distance visual acuity.
studied IntraLase FS 60 kHz, the average SD was 12.4 µm. 
For FEMTO LDV, the reproducibility, the average SD was 
8.2 µm. For Visumax, the average SD was 23.3 µm and for 
Wavelight FS200 14.3 µm.
Complication rates
Among the different IntraLase types, IntraLase FS 10 kHz20 had 
no intraoperative complications, but postoperative complica-
tion rate was 37.5% (one study was included; Figures 6 and 7). 
IntraLase FS 15 kHz33–35,41 had no intraoperative complications, 
but the average postoperative complication rate was 18.0%. 
IntraLase FS 30 kHz31,37 had no intraoperative complications, 
while the percentage for postoperative complication was 2.6%. 
IntraLase FS 60 kHz13–19 had the average intraoperative and 
postoperative complication rates of 1.4% and 3.2%, respec-
tively. IntraLase 150 kHz19,24 had the average intraoperative 
complication rate of 0.9% and postoperative complication 
rate of 0%. FEMTO LDV26,27 had the average intraoperative 
complication rate of 11.8%. The postoperative complication 
rate for FEMTO LDV averaged 9.9%. For Visumax,24,28 intra-
operative and postoperative complication rates averaged 3.3% 
and 0.2%, respectively. Wavelight FS20029,30 had the lowest 
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Figure 5 Corneal flap measurements after FS laser for LASIK.
Abbreviations: F, F factor; FS, femtosecond; LASIK, laser-assisted in situ keratomileusis; ns, nonsignificant; SD, standard deviation.
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Figure 4 Safety, the proportion of eyes losing two or more Snellen lines of CDVA after FS laser for LASIK.
Abbreviations: CDVA, corrected distance visual acuity; χ2, chi-square statistic; CI, confidence interval; df, degrees of freedom; FS, femtosecond; LASIK, laser-assisted in situ 
keratomileusis; ns, nonsignificant.
intraoperative and postoperative complication rates of 0.4% 
and 0%, respectively.
Discussion
This meta-analysis compared different types of FS lasers for 
LASIK. In the literature search, we found 109 potentially 
relevant abstracts for review, but only 47 were suitable for 
a full paper review. Additionally, we included one study33 
from the previously published meta-analyses.10,11 From 
these 48 articles, we excluded 17 papers based on lacking or 
duplicate data, and the final analysis included 31 articles. For 
primary outcome measures, hyperopic eyes were excluded. 
No studies were excluded from the analysis due to the low-
quality scoring by Jadad et al system.12
The different FS laser systems can be classified into 
two groups: one group is characterized with high pulse 
energy–low pulse frequency (such as IntraLase and 
Femtec) and the other with low pulse energy–high pulse 
frequency (such as FEMTO LDV and Wavelight FS200).7 
In the FS laser technology in the high pulse energy–low 
pulse frequency group, pulse energies are in the range of 
1 µJ and repetition rates on the order of kilohertz.7 The 
low pulse energy–high pulse frequency system delivers 
only pulse energy on the order of nano-joule and uses 
megahertz repetition rates.7 From all FS lasers on the 
market, IntraLase was the first introduced and different 
IntraLase FS types (10, 15, 30, 60, and 150 kHz) are the 
most commonly reported.
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Figure 6 Intraoperative complications after FS laser for LASIK.
Abbreviations: χ2, chi-square statistic; CI, confidence interval; df, degrees of freedom; FS, femtosecond; IO, intraoperative; LASIK, laser-assisted in situ keratomileusis.
The pooled primary outcome results showed that there 
was a statistically significant difference in the proportion 
of eyes within a UDVA of 20/20 or better (efficacy). Based 
on efficacy, IntraLase and FEMTO LDV gave the best 
results. There were also statistically significant differences 
in the mean spherical equivalent refraction within ±0.5 D 
of target refraction (predictability). Based on predictability, 
IntraLase types FS 15, FS 30, and FS 60 kHz were the best. 
There was no statistically significant difference in the loss 
of $2 Snellen lines of CDVA (safety) between different 
FS lasers.
It was difficult to combine the results of randomized con-
trolled trials because of different follow-up times. In the 31 
studies chosen for this meta-analysis, the follow-up time was #1 
month in five studies.14,32,37,39,42 The most commonly reported 
follow-up times were 3 months (ten studies) 18,20,22,24,30,31,33,36,38,50 
and 6 months (eight studies).13,15,21,26–29,41 The follow-up time 
was $1 year only in seven cases.16,17,19,23,25,34,35 Long follow-up 
times should be recommended for reporting refractive results, 
especially in controlled randomized studies. In the meta-
analysis, different excimer laser choices used in LASIK made 
it also more difficult to compare refractive results. Another 
drawback of this meta-analysis is that due to limited reporting, 
the results were pooled together from standard, wavefront-
guided, and wavefront-optimized treatments, and there was 
no compensation for this.
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Figure 7 Postoperative complications after FS laser for LASIK.
Abbreviations: χ2, chi-square statistic; CI, confidence interval; df, degrees of freedom; FS, femtosecond; LASIK, laser-assisted in situ keratomileusis; PO, postoperative.
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Mechanical microkeratomes typically create meniscus-
shaped flaps that are thinner in the center and thicker in the 
periphery, whereas FS laser flaps have been found to be 
typically more uniformly planar.43–47 Preliminary studies 
with the IntraLase FS laser have demonstrated that free 
flaps, irregular flaps, microperforations, decentered flaps, 
epithelial defects, and abrasions were significantly reduced 
or eliminated.48–50 The SD of achieved flap thickness with 
FS lasers has also been found to be narrower than with 
mechanical systems.4,46
Although in this meta-analysis flap thickness measure-
ments and complication rates were classified as secondary 
outcomes from the surgeons’ point of view, they are in fact 
the areas of major concern in LASIK. In the meta-analysis, 
the pooled secondary outcome results showed some varia-
tions between different FS lasers. Based on the SD of the 
measured flap thicknesses, FEMTO LDV reproduced the 
most accurate flap thicknesses.
Certain complications have been shown to be unique to 
the FS laser, such as transient opaque bubble layer (OBL),51–55 
especially with the IntraLase, transient light sensitivity 
syndrome,56,57 increased corneal backscatter,41 and rainbow 
glare.58–60 The incidence of transient OBL, transient light sen-
sitivity syndrome, and rainbow glare has reduced with lower 
energies used. In this meta-analysis, IntraLase and Wavelight 
SF200 had the fewest intraoperative complications. IntraLase 
FS 60 kHz, Visumax, and Wavelight FS200 had the most 
seldom postoperative complications. In the meta-analysis, 
it was difficult to compare the complications based on the 
percentage of complications reported in the studies. In general, 
there were very few intraoperative complications reported. 
The most common intraoperative complications were a loss 
of suction, OBL, and adhesions. The most frequently reported 
postoperative complications were diffuse lamellar keratitis 
and microstriae. No ectasia was found in these studies. How-
ever, there seemed to be big differences between authors in 
reporting complications in LASIK. For instance, in the first 
FEMTO LDV study that reported the results of a preproduc-
tion FS laser system, its intraoperative complication rate was 
17.1% and postoperative complication rate was 14.4%.26 
Furthermore, there was a mild epithelial sloughing in 11.8% 
of the eyes. Yet, in another FEMTO LDV study, there were no 
complications.27 Therefore, we suggest a standardized system 
for reporting complications in refractive surgery. Intraopera-
tive side effects that do not have any effects on the refractive 
outcome should also be reported, such as OBL, decentered, 
incomplete or free flaps, and flap adhesion. Bleeding from 
the limbal vessels should also be reported.
Conclusion
In conclusion, there were dissimilarities between different FS 
lasers based on efficacy and intraoperative and postoperative 
complications. All FS lasers were predictable and safe for 
making corneal flaps in LASIK.
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